IGC
Price
$0.34
Change
-$0.00 (-0.00%)
Updated
Jan 17 closing price
Capitalization
26.33M
25 days until earnings call
TECX
Price
$40.90
Change
-$1.12 (-2.67%)
Updated
Jan 17 closing price
Capitalization
603.38M
Ad is loading...

IGC vs TECX

Header iconIGC vs TECX Comparison
Open Charts IGC vs TECXBanner chart's image
IGC Pharma
Price$0.34
Change-$0.00 (-0.00%)
Volume$139.07K
Capitalization26.33M
Tectonic Therapeutic
Price$40.90
Change-$1.12 (-2.67%)
Volume$199.64K
Capitalization603.38M
IGC vs TECX Comparison Chart
Loading...
IGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IGC vs. TECX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IGC is a Hold and TECX is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (IGC: $0.34 vs. TECX: $40.90)
Brand notoriety: IGC and TECX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IGC: 32% vs. TECX: 164%
Market capitalization -- IGC: $26.33M vs. TECX: $603.38M
IGC [@Biotechnology] is valued at $26.33M. TECX’s [@Biotechnology] market capitalization is $603.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IGC’s FA Score shows that 0 FA rating(s) are green whileTECX’s FA Score has 0 green FA rating(s).

  • IGC’s FA Score: 0 green, 5 red.
  • TECX’s FA Score: 0 green, 5 red.
According to our system of comparison, TECX is a better buy in the long-term than IGC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IGC’s TA Score shows that 4 TA indicator(s) are bullish while TECX’s TA Score has 3 bullish TA indicator(s).

  • IGC’s TA Score: 4 bullish, 5 bearish.
  • TECX’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, TECX is a better buy in the short-term than IGC.

Price Growth

IGC (@Biotechnology) experienced а -1.48% price change this week, while TECX (@Biotechnology) price change was +1.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

IGC is expected to report earnings on Jun 18, 2025.

TECX is expected to report earnings on Aug 08, 2024.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TECX($603M) has a higher market cap than IGC($26.3M). IGC YTD gains are higher at: 1.161 vs. TECX (-11.414). TECX has more cash in the bank: 159M vs. IGC (1.55M). IGC has less debt than TECX: IGC (304K) vs TECX (2.98M).
IGCTECXIGC / TECX
Capitalization26.3M603M4%
EBITDA-8.69MN/A-
Gain YTD1.161-11.414-10%
P/E RatioN/AN/A-
Revenue1.18MN/A-
Total Cash1.55M159M1%
Total Debt304K2.98M10%
FUNDAMENTALS RATINGS
IGC vs TECX: Fundamental Ratings
IGC
TECX
OUTLOOK RATING
1..100
962
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
48
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
6234
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IGC's Valuation (48) in the Biotechnology industry is in the same range as TECX (48) in the null industry. This means that IGC’s stock grew similarly to TECX’s over the last 12 months.

IGC's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as TECX (100) in the null industry. This means that IGC’s stock grew similarly to TECX’s over the last 12 months.

IGC's SMR Rating (98) in the Biotechnology industry is in the same range as TECX (100) in the null industry. This means that IGC’s stock grew similarly to TECX’s over the last 12 months.

TECX's Price Growth Rating (34) in the null industry is in the same range as IGC (62) in the Biotechnology industry. This means that TECX’s stock grew similarly to IGC’s over the last 12 months.

TECX's P/E Growth Rating (100) in the null industry is in the same range as IGC (100) in the Biotechnology industry. This means that TECX’s stock grew similarly to IGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IGCTECX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 11 days ago
90%
Bullish Trend 11 days ago
88%
Momentum
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 11 days ago
88%
MACD
ODDS (%)
Bearish Trend 11 days ago
79%
N/A
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
85%
Bearish Trend 11 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
84%
Bearish Trend 11 days ago
87%
Advances
ODDS (%)
Bullish Trend about 1 month ago
84%
Bullish Trend 24 days ago
84%
Declines
ODDS (%)
Bearish Trend 19 days ago
83%
Bearish Trend 11 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 11 days ago
85%
N/A
Aroon
ODDS (%)
Bullish Trend 11 days ago
88%
Bullish Trend 11 days ago
86%
View a ticker or compare two or three
Ad is loading...
IGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRPAX6.440.04
+0.62%
PGIM Jennison Energy Infrastructure A
LZFIX8.320.05
+0.60%
Lazard Equity Franchise Inst Shr
JHUJX29.470.16
+0.55%
JPMorgan Emerging Markets Equity R2
RYCUX40.650.03
+0.07%
Rydex Utilities C
PHSZX43.32-0.44
-1.01%
PGIM Jennison Health Sciences Z

IGC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IGC has been loosely correlated with TECX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if IGC jumps, then TECX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IGC
1D Price
Change %
IGC100%
N/A
TECX - IGC
37%
Loosely correlated
-2.67%
ANVS - IGC
30%
Poorly correlated
N/A
AMLX - IGC
30%
Poorly correlated
+2.86%
VNDA - IGC
27%
Poorly correlated
-1.80%
VTGN - IGC
27%
Poorly correlated
N/A
More

TECX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TECX has been loosely correlated with SRPT. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if TECX jumps, then SRPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TECX
1D Price
Change %
TECX100%
-2.67%
SRPT - TECX
59%
Loosely correlated
+0.80%
IGC - TECX
37%
Loosely correlated
N/A
ANEB - TECX
31%
Poorly correlated
-1.55%
MMIRF - TECX
28%
Poorly correlated
N/A
GOVX - TECX
24%
Poorly correlated
-0.89%
More